Prescription Required.Why?
Is an antihistamine that blocks the effects of histamine, a substance that the body releases during allergic reactions.
Is a leukotriene receptor antagonist that blocks the effects of leukotrienes, substances that cause inflammation in the airways.
Ebastine + Montelukast is commonly prescribed for the treatment of seasonal allergic rhinitis (hay fever), such as sneezing, runny nose, itchy eyes, and nasal congestion.
It can also be used for the treatment of perennial allergic rhinitis, which is yearround allergic rhinitis triggered by dust mites, mold, or pet dander.
In some cases, it might be used for the treatment of mild to moderate asthma.
Ebazen M Tab (Ebastine + Montelukast) works by blocking the release of histamine and other chemicals that cause inflammation in the airways and nasal passages, resulting in symptom relief.
Store the medication at room temperature, away from direct sunlight and moisture. Keep it out of reach of children and pets.
The dosage of Ebastine + Montelukast varies depending on the individual's age, weight, and the severity of their condition.
It is typically taken once daily, with or without food.
It is important to follow the doctor's instructions and not exceed the recommended dosage.
This drug comes in tablet form and should be swallowed whole with a glass of water.
Common side effects include headache, drowsiness, dizziness, nausea, and diarrhea.
Alcohol consumption may worsen the drowsiness caused by Ebastine + Montelukast.
Ebastine + Montelukast can cause drowsiness and dizziness. Therefore, it is advisable to avoid driving or operating machinery until you know how this medication affects you.
The safety of Ebastine + Montelukast during pregnancy and breastfeeding has not been established. It is recommended to consult with your doctor before using this medication if you are pregnant or breastfeeding.
The use of Ebastine + Montelukast in children should be guided by a doctor's recommendation.
Ebastine + Montelukast is primarily metabolized by the liver and excreted through the kidneys. While kidney impairment does not significantly affect its elimination, monitoring may be necessary for individuals with severe kidney disease.
Ebastine + Montelukast is primarily metabolized by the liver. In individuals with liver disease, the dosage may need to be adjusted or the medication avoided altogether. Close monitoring for liver function is recommended.
Your healthcare provider
The medication guide provided with the medication
The US Food and Drug Administration (FDA) website
Reputable medical journals and databases
